Drug treatment for the sickest COVID patients
CINCINNATI—Earlier this year, we reported that the FDA accepted Airway Therapeutics’ application for an investigational drug treatment designed to help some of the sickest coronavirus patients recover. The first patient has been dosed in a Phase 1b trial of AT-100 in severe COVID-19 patients and seems to be on the mend.
COVID and protease inhibitors
Improving the logistics space
GRAND RAPIDS, MI—The pandemic has affected customer needs in the e-commerce and logistics spaces, with expectations for product delivery times becoming shorter. Dematic Corp., a supplier of material handling systems, software and solutions, has a $3 billion tech center, where it is shifting more of its focus to increasingly complex forms of conveyance solutions.
Don’t skip the second vaccine dose